Cart
sales@molnova.com
Notoginsenoside Fc
CAS No. 88122-52-5
Notoginsenoside Fc( —— )
Catalog No. M19221 CAS No. 88122-52-5
Notoginsenoside Fc has perfect anti-platelet aggregatory effect.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 2MG | 46 | In Stock |
|
| 5MG | 73 | In Stock |
|
| 10MG | 117 | In Stock |
|
| 25MG | 187 | In Stock |
|
| 50MG | 272 | In Stock |
|
| 100MG | 405 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameNotoginsenoside Fc
-
NoteResearch use only, not for human use.
-
Brief DescriptionNotoginsenoside Fc has perfect anti-platelet aggregatory effect.
-
DescriptionNotoginsenoside Fc has perfect anti-platelet aggregatory effect.
-
In VitroNotoginsenoside Fc (20 μM; for 24?h) markedly upregulates the expression of LC3B and Beclin 1 and downregulated that of p62 in RAOECs.
-
In VivoNotoginsenoside Fc (3.5?mg/kg/day) accelerates reendothelialization and alleviates excessive neointimal formation following carotid artery injury in diabetic Sprague-Dawley rats (200±20?g) in vivo.
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
RecptorOthers
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number88122-52-5
-
Formula Weight1211.38
-
Molecular FormulaC58H98O26
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 100 mg/mL (82.55 mM)
-
SMILESCC(=CCCC(C)(C1CCC2(C1C(CC3C2(CCC4C3(CCC(C4(C)C)OC5C(C(C(C(O5)CO)O)O)OC6C(C(C(C(O6)CO)O)O)OC7C(C(C(CO7)O)O)O)C)C)O)C)OC8C(C(C(C(O
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
-
N-[2-nitro-4-(triflu...
N-[2-nitro-4-(trifluoromethyl)phenyl]piperazine is a biologically active compound belonging to the piperazine group.
-
(R)-Omeprazole Sodiu...
(R)-Omeprazole (sodium) (Standard) is the analytical standard of (R)-Omeprazole (sodium). This product is intended for research and analytical applications. (R)-Omeprazole sodium is a gastric acid resistant compound with activity to inhibit gastric acid secretion. (R)-Omeprazole sodium is metabolized in vivo, and its metabolism is primarily affected by cytochrome P450 enzymes. The interaction between (R)-Omeprazole sodium and mannitol may affect its bioavailability in formulations. (R)-Omeprazole sodium exhibits reversible direct and metabolism-dependent inhibition of CYP2C19.
-
3,4,5-Triiodobenzoic...
3,4,5-Triiodobenzoic acid is inhibitor of thiopurine methyltransferase (TPMT).
